Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 3.

Berner, Fiamma; Bomze, David; Diem, Stefan; Ali, Omar Hasan; Fässler, Mirjam; Ring, Sandra; Niederer, Rebekka; Ackermann, Christoph J; Baumgaertner, Petra; Pikor, Natalia; Cruz, Cristina Gil; van de Veen, Willem; Akdis, Mübeccel; Nikolaev, Sergey; Läubli, Heinz; Zippelius, Alfred; Hartmann, Fabienne; Cheng, Hung-Wei; Hönger, Gideon; Recher, Mike; Goldman, Jonathan; Cozzio, Antonio; Früh, Martin; Neefjes, Jacques; Driessen, Christoph; Ludewig, Burkhard; Hegazy, Ahmed N; Jochum, Wolfram; Speiser, Daniel E; Flatz, Lukas; et al (2019). Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer. JAMA Oncology, 5(7):1043.

Hasan Ali, Omar; Berner, Fiamma; Bomze, David; Fässler, Mirjam; Diem, Stefan; Cozzio, Antonio; Jörger, Markus; Früh, Martin; Driessen, Christoph; Lenz, Tobias L; Flatz, Lukas (2019). Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors. European Journal of Cancer, 107:8-14.

Driessen, Christoph; Kraus, Marianne; Joerger, Markus; Rosing, Hilde; Bader, Jürgen; Hitz, Felicitas; Berset, Catherine; Xyrafas, Alexandros; Hawle, Hanne; Berthod, Gregoire; Overkleeft, Hermann S; Sessa, Cristiana; Huitema, Alwin; Pabst, Thomas; von Moos, Roger; Hess, Dagmar; Mey, Ulrich J M (2016). Treatment with the HIV protease inhibitor Nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08). Haematologica, 101(3):346-355.

This list was generated on Mon Aug 26 00:03:54 2019 CEST.